Radius health, inc. (RDUS)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
REVENUES:
Product revenue, net

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

OPERATING EXPENSES:
Cost of sales - product

16,118

15,287

13,552

11,774

9,569

7,627

5,458

3,518

2,020

932

358

105

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales - intangible amortization

798

798

799

799

799

799

800

800

600

400

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

132,507

116,757

106,161

101,174

100,319

99,911

98,879

93,072

86,400

83,076

85,755

92,211

99,450

107,406

104,053

94,817

84,204

68,280

57,621

53,221

47,561

45,719

45,618

47,344

52,966

60,536

65,492

64,122

62,381

54,961

46,382

39,855

41,909

36,179

31,397

25,967

0

0

0

Selling, general and administrative

147,951

152,704

160,817

168,861

177,325

184,164

190,999

195,061

196,603

186,677

163,406

134,923

101,995

77,542

61,664

50,880

39,687

30,797

24,841

19,221

16,291

13,674

10,231

9,016

7,390

6,829

7,903

8,200

8,935

9,469

8,476

7,779

6,545

5,330

4,098

3,350

0

0

0

Other operating expense

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Loss from operations

-105,978

-112,229

-129,253

-149,659

-184,277

-204,063

-234,459

-244,944

-248,964

-248,973

-235,270

-226,259

-201,445

-184,948

-165,717

-145,697

-123,891

-99,077

-82,462

-72,442

-63,852

-59,393

-55,849

-56,360

-60,356

-67,365

-73,395

-72,322

-71,316

-64,430

-54,858

-47,634

-48,454

-41,509

-35,965

-29,787

0

0

0

OTHER INCOME (EXPENSE):
Other income (expense)

249

242

-4

-46

167

59

104

-108

-376

-192

-331

-214

-212

-293

-82

-3

14

-35

-131

-132

1,673

-510

1,114

-1,493

-4,404

9,085

7,158

9,161

9,628

-2,095

-1,745

-1,442

-713

-236

-274

12

0

0

0

Interest expense

25,654

24,935

24,413

23,908

23,426

22,955

22,577

19,547

13,864

8,298

0

0

0

-

0

-

-

1,885

2,699

3,207

2,863

2,467

2,155

1,935

2,143

2,440

2,725

2,996

2,922

2,667

2,138

1,393

0

-

0

0

-

-

-

Loss on retirement of note payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

3,496

3,929

4,294

4,479

4,994

5,622

5,676

5,302

4,351

3,226

2,424

2,190

2,377

2,437

2,475

2,164

1,605

1,043

616

377

197

94

45

21

30

30

38

45

49

64

58

42

30

27

43

62

0

0

0

Net Income (Loss) Attributable to Parent

-127,887

-132,993

-149,376

-169,134

-202,542

-221,337

-251,256

-259,297

-258,853

-254,237

-235,940

-224,283

-199,280

-182,804

-163,324

-145,402

-124,932

-101,526

-86,248

-75,404

-65,048

-62,479

-57,048

-59,970

-66,873

-60,690

-68,924

-66,112

-64,561

-69,128

-58,817

-50,711

-50,338

-42,476

-36,572

0

0

0

-

OTHER COMPREHENSIVE LOSS:
Unrealized gain (loss) from available-for-sale debt securities

-385

758

870

1,246

1,202

-441

-850

-1,293

-1,517

-385

-51

-186

-203

66

-47

178

196

26

109

21

0

-

0

0

-

-

0

0

-

-5

0

0

0

-

-

-

-

-

-

COMPREHENSIVE LOSS

-128,272

-132,235

-148,506

-167,888

-201,340

-221,778

-252,106

-260,590

-260,370

-254,622

-235,991

-224,469

-199,483

-182,738

-163,371

-145,224

-124,736

-101,500

-86,139

-75,395

-65,007

-62,500

-57,058

-59,972

-66,873

-60,690

-68,927

-66,119

-64,565

-69,133

-58,814

-50,701

-50,334

-42,468

0

0

0

-

0

LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS - BASIC AND DILUTED (Note 8)

-127,887

-132,993

-149,376

-169,134

-202,542

-221,337

-251,256

-259,297

-258,853

-254,237

-43,630

60,399

85,402

182,804

76,454

58,532

124,932

101,526

193,282

147,598

107,993

71,479

-70,821

-78,491

-85,731

-78,161

-85,244

-81,244

-78,781

-83,120

-40,045

-30,905

-8,087

253

-26,767

-20,216

0

0

0

Earnings Per Share [Abstract]
Earnings Per Share, Basic and Diluted

-0.81

-0.53

-0.65

-0.77

-0.94

-0.90

-1.09

-1.52

-1.37

-1.59

-1.31

-1.58

-1.32

-1.22

-1.07

-1.01

-0.94

-0.80

-0.68

-0.61

-0.47

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.59

-2.22

-50.45

-

-65.05

-62.59

-31.25

-

-24.53

-25.06

-20.92

42.22

-20.17

2.89

-24.43

-25.97

-16.85

Diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.59

-2.22

-50.45

-

-65.05

-62.59

-31.25

-

-24.53

-25.06

-20.92

44.23

-20.17

0.44

-24.43

-25.97

-16.85

Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted Average Number of Shares Outstanding, Basic and Diluted

46,271

46,182

46,141

46,109

45,671

45,557

45,498

45,430

44,937

44,623

43,999

43,410

43,185

43,123

43,092

43,042

43,012

43,076

41,331

37,895

36,268

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,746

7,500

385

-

385

381

380

-

859

854

775

600

592

484

322

320

320

Diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,746

7,500

385

-

385

381

380

-

859

854

775

9,726

592

3,175

322

320

320

Product
Revenue from Contract with Customer, Excluding Assessed Tax

-

-

152,076

132,949

-

99,239

72,478

48,308

26,659

12,112

4,449

980

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License
Revenue from Contract with Customer, Excluding Assessed Tax

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-